Cargando…
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512527/ https://www.ncbi.nlm.nih.gov/pubmed/36150168 http://dx.doi.org/10.1182/blood.2022016815 |
| _version_ | 1784797858197667840 |
|---|---|
| author | Blixt, Lisa Gao, Yu Wullimann, David Murén Ingelman-Sundberg, Hanna Muschiol, Sandra Healy, Katie Bogdanovic, Gordana Pin, Elisa Nilsson, Peter Kjellander, Christian Grifoni, Alba Sette, Alessandro Sällberg Chen, Margaret Ljunggren, Hans-Gustaf Buggert, Marcus Hansson, Lotta Österborg, Anders |
| author_facet | Blixt, Lisa Gao, Yu Wullimann, David Murén Ingelman-Sundberg, Hanna Muschiol, Sandra Healy, Katie Bogdanovic, Gordana Pin, Elisa Nilsson, Peter Kjellander, Christian Grifoni, Alba Sette, Alessandro Sällberg Chen, Margaret Ljunggren, Hans-Gustaf Buggert, Marcus Hansson, Lotta Österborg, Anders |
| author_sort | Blixt, Lisa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9512527 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95125272022-09-27 Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination Blixt, Lisa Gao, Yu Wullimann, David Murén Ingelman-Sundberg, Hanna Muschiol, Sandra Healy, Katie Bogdanovic, Gordana Pin, Elisa Nilsson, Peter Kjellander, Christian Grifoni, Alba Sette, Alessandro Sällberg Chen, Margaret Ljunggren, Hans-Gustaf Buggert, Marcus Hansson, Lotta Österborg, Anders Blood Letter to Blood The American Society of Hematology 2022-12-01 2022-09-27 /pmc/articles/PMC9512527/ /pubmed/36150168 http://dx.doi.org/10.1182/blood.2022016815 Text en © 2022 by The American Society of Hematology. |
| spellingShingle | Letter to Blood Blixt, Lisa Gao, Yu Wullimann, David Murén Ingelman-Sundberg, Hanna Muschiol, Sandra Healy, Katie Bogdanovic, Gordana Pin, Elisa Nilsson, Peter Kjellander, Christian Grifoni, Alba Sette, Alessandro Sällberg Chen, Margaret Ljunggren, Hans-Gustaf Buggert, Marcus Hansson, Lotta Österborg, Anders Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination |
| title | Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination |
| title_full | Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination |
| title_fullStr | Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination |
| title_full_unstemmed | Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination |
| title_short | Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination |
| title_sort | hybrid immunity in immunocompromised patients with cll after sars-cov-2 infection followed by booster mrna vaccination |
| topic | Letter to Blood |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512527/ https://www.ncbi.nlm.nih.gov/pubmed/36150168 http://dx.doi.org/10.1182/blood.2022016815 |
| work_keys_str_mv | AT blixtlisa hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT gaoyu hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT wullimanndavid hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT mureningelmansundberghanna hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT muschiolsandra hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT healykatie hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT bogdanovicgordana hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT pinelisa hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT nilssonpeter hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT kjellanderchristian hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT grifonialba hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT settealessandro hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT sallbergchenmargaret hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT ljunggrenhansgustaf hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT buggertmarcus hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT hanssonlotta hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination AT osterborganders hybridimmunityinimmunocompromisedpatientswithcllaftersarscov2infectionfollowedbyboostermrnavaccination |